Christopher A. Kroeger

Christopher A. Kroeger is a declared insider of MapLight Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 15 filings; the first trade dates from 27 October 2025 and the latest from 15 October 2026.

On the market, this insider has only sold: 11 sales, €5.7M in total. Outside the open market, there are 4 share grants. So far in 2026, the count stands at no purchases and 11 sales.

The record was last updated on 16 October 2026 with an open-market sale (€531k) in MapLight Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.